Vous n'êtes pas connecté
In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of therapy involves labeling the CD20 protein on the surface of the B cells with customised antibodies. This triggers a chain of immunological reactions and ultimately leads to the destruction of the cancer cells. Such immunotherapeutic antibodies [...]